aTyr Pharma, Inc.ATYRNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank85
3Y CAGR+0.1%
5Y CAGR+43.5%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+0.1%/yr
vs +14.5%/yr prior
5Y CAGR
+43.5%/yr
Recent deceleration
Acceleration
-14.4pp
Decelerating
Percentile
P85
Within normal range
vs 5Y Ago
6.1x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $55.29M | -18.9% |
| 2024 | $68.15M | +23.3% |
| 2023 | $55.27M | +0.3% |
| 2022 | $55.09M | +68.4% |
| 2021 | $32.71M | +260.5% |
| 2020 | $9.07M | -3.0% |
| 2019 | $9.35M | -70.8% |
| 2018 | $32.07M | -30.9% |
| 2017 | $46.43M | -20.5% |
| 2016 | $58.44M | - |